MedPath
FDA Approval

Tavaborole

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 15, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Tavaborole(43.5 mg in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Inc.

Alembic Pharmaceuticals Limited

871411532

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tavaborole

Product Details

NDC Product Code
62332-467
Application Number
ANDA212188
Marketing Category
ANDA (C73584)
Route of Administration
TOPICAL
Effective Date
December 15, 2023
Code: K124A4EUQ3Class: ACTIBQuantity: 43.5 mg in 1 mL
ALCOHOLInactive
Code: 3K9958V90MClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
EDETATE CALCIUM DISODIUMInactive
Code: 25IH6R4SGFClass: IACT
© Copyright 2025. All Rights Reserved by MedPath